The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer.
about
Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies.Lung cancer staging: clinical and radiologic perspectivesNew TNM classification: achievements and hurdlesPhase I trial of induction histone deacetylase and proteasome inhibition followed by surgery in non-small-cell lung cancer.Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.A pooled exploratory analysis of the effect of tumor size and KRAS mutations on survival benefit from adjuvant platinum-based chemotherapy in node-negative non-small cell lung cancerNodal Upstaging Is More Common with Thoracotomy than with VATS During Lobectomy for Early-Stage Lung Cancer: An Analysis from the National Cancer Data BaseImproved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data.Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy.Prognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma-a systematic literature review and pooled-data analysis.Multidisciplinary Evaluation of Patients With Suspected Lung Cancer.Relationship between tumor size and disease stage in non-small cell lung cancer.Extent of Visceral Pleural Invasion Affects Prognosis of Resected Non-small Cell Lung Cancer: A meta-analysisPrognostic factors in resected lung carcinomas.Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.Hypertrophic pulmonary osteoarthropathy with primary lung cancer.Application of the new 8th TNM staging system for non-small cell lung cancer: treated with curative concurrent chemoradiotherapyCirculating tumor microemboli diagnostics for patients with non-small-cell lung cancer.N2 disease in T1 non-small cell lung cancer.Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.Risk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patientsRe-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set.Opportunities for NanoTheranosis in Lung Cancer and Pulmonary Metastasis.Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.Multiple marker detection in peripheral blood for NSCLC diagnosisClinical characteristics and prognosis of incidentally detected lung cancersVisceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size.Are we ready to use biomarkers for staging, prognosis and treatment selection in early-stage non-small-cell lung cancer?Sublobar resection for early-stage lung cancer.Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registryImaging of lung cancer: Implications on staging and management.Clinical and surgical-pathological staging in early non-small cell lung cancer.Photodynamic therapy for the treatment of non-small cell lung cancer.Pleural Photodynamic Therapy and Surgery in Lung Cancer and Thymoma Patients with Pleural Spread.Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research.Multi-institutional analysis of T3 subtypes and adjuvant radiotherapy effects in resected T3N0 non-small cell lung cancer patients.A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial).Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age-challenges and opportunitiesStaging non-small cell lung cancerImprovement of cellularity on cell block preparations using the so-called tissue coagulum clot method during endobronchial ultrasound-guided transbronchial fine-needle aspiration.
P2860
Q24289207-033E86A1-F544-4C84-9F83-58B174E7843AQ24600394-94BBFD60-DE4E-419C-B43B-21057774FE01Q27022737-3CFAE993-472D-4497-A410-8B24DBC0C024Q30416647-2797B8B5-756D-428F-AFC2-11A9CDA81ED0Q30438068-FCA0BEDB-1C30-46AE-B64C-3365A75813E4Q30539299-C3D1CCF1-5570-4C42-A1A3-0F9D4280B211Q30702531-82D953C0-3BBF-4DAE-878B-92F1B0F5C63CQ30985297-2A912B79-3812-4D6C-84BA-10DE3FAC3841Q30993385-CDA30D2B-425D-44A3-B952-AA6531E79188Q31034428-5BE33AB4-CD80-49FA-86F6-0E867A7D0C15Q33599661-28B54F96-662D-43CC-9B3A-62C5CA9A7E27Q33682854-B2F488A8-ECE7-4A02-B705-AA91356C07C3Q33685604-4E00D838-6AB4-4C13-A23D-0361516BE100Q33697964-D68BA550-EBBB-45E2-BB43-3A28E5CD83F4Q33710746-6B0F3991-FD22-455F-906A-63D4CAFF5A3BQ33727507-497C3858-5B43-4E8E-8484-BC8DFB1B4B74Q33922698-A71999CB-31F9-46E5-A2D8-6F51B20C1A04Q34093217-B3FA6A26-9401-43AF-B843-881FE6DED7CCQ34094782-9DD48124-F64F-45A0-8EA9-E44200A5E572Q34175045-4E214910-5FA9-4D99-9BEB-A0B94FEEFF78Q34208219-7905166D-2237-4310-BB7F-9BA27D428C02Q34435251-63D01681-C055-4BC3-A8F1-A505C962A4C1Q34441122-6978C508-316C-4693-9176-3D09862CB7CCQ34552929-49E837E8-03A4-48BC-8A54-D4FDE1CAFB3CQ34612077-4741E600-3C65-4BB2-9D65-6746D27FEFE3Q35061539-2E51F053-29C0-4210-9BF4-907A52225EC3Q35194720-5BDA3747-7C3E-4E57-9FBA-3879E471DD3BQ35200402-679FC512-2350-4672-81E1-A36EFBFBB9FDQ35200550-6D053B3A-15F4-4868-A373-145AD12AF46CQ35202454-079C4EBA-9824-41F2-90BE-291C318ABDFBQ35568718-107DEA59-00BC-430D-8E73-A4CF7DF75660Q35569308-97C082A4-67C8-4218-8D87-9C99692E2B62Q35667899-19513793-D946-4705-A82B-6E551B98CB6BQ35699917-6DFAF2EE-F4CD-42E6-A48E-AA5B5A22DB22Q35771994-888D689D-E9CE-4086-A813-6905EEF9D8E3Q35824260-F34F588F-4778-4AA5-B3CB-3A970F94823BQ35873571-C714E24B-69C1-4637-99F7-564E41AE4A60Q35996028-F5FA0DBF-2DEB-4BA2-8A13-A65089BD9B99Q36129173-B8437740-6FAF-43DA-93B4-4642C658D869Q36130519-94CB4C8F-DDAC-4FCE-A2D8-BEA9956DB7CE
P2860
The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
The IASLC Lung Cancer Staging ...... lassification for lung cancer.
@en
The IASLC Lung Cancer Staging ...... descriptors in the forthcoming
@nl
type
label
The IASLC Lung Cancer Staging ...... lassification for lung cancer.
@en
The IASLC Lung Cancer Staging ...... descriptors in the forthcoming
@nl
prefLabel
The IASLC Lung Cancer Staging ...... lassification for lung cancer.
@en
The IASLC Lung Cancer Staging ...... descriptors in the forthcoming
@nl
P2093
P1476
The IASLC Lung Cancer Staging ...... classification for lung cancer
@en
P2093
Cancer Research and Biostatistics
David Ball
Dorothy J Giroux
International Staging Committee
James Jett
John Crowley
Masahiro Tsuboi
Observers to the Committee
Participating Institutions
Peter Goldstraw
P304
P356
10.1097/JTO.0B013E31807A2F81
P577
2007-07-01T00:00:00Z